← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2018Last known activity
Mar 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05277987Lead sponsorEarly Phase 1Mar 31, 2022
- NCT05277987Reponsible party - principal investigatorEarly Phase 1Mar 31, 2022
- NCT03777930Lead sponsorPhase 4Dec 10, 2018
- NCT03662477Reponsible party - principal investigatorEarly Phase 1Jan 1, 2018
- NCT03662477Lead sponsorEarly Phase 1Jan 1, 2018
Details
- Last known activity
- Mar 31, 2022